Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.

Ruiz-García R, Martínez-Hernández E, García-Ormaechea M, Español-Rego M, Sabater L, Querol L, Illa I, Dalmau J, Graus F.

Front Immunol. 2019 Apr 12;10:769. doi: 10.3389/fimmu.2019.00769. eCollection 2019.

2.

Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.

Pedreño M, Sepúlveda M, Armangué T, Sabater L, Martínez-Hernandez E, Arrambide G, Blanco Y, Llufriu S, Martínez-Lapiscina EH, Mulero P, Sola-Valls N, Ruiz-García R, Tintoré M, Dalmau J, Graus F, Saiz A.

Mult Scler Relat Disord. 2019 Feb;28:230-234. doi: 10.1016/j.msard.2019.01.007. Epub 2019 Jan 3.

PMID:
30623863
3.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Maddison P, Titulaer MJ, Verschuuren JJ, Gozzard P, Lang B, Irani SR, Sabater L, Graus F, Murray A, Chapman CJ.

J Neuroimmunol. 2019 Jan 15;326:14-18. doi: 10.1016/j.jneuroim.2018.11.003. Epub 2018 Nov 8.

4.

LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.

Petit-Pedrol M, Sell J, Planagumà J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C.

Brain. 2018 Nov 1;141(11):3144-3159. doi: 10.1093/brain/awy253.

PMID:
30346486
5.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

6.

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.

van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M, Will LM, Hulsenboom E, Demonet JF, Sabater L, Kros JM, Verschuuren JJGM, Titulaer MJ, de Graaff E, Sillevis Smitt PAE, Hoogenraad CC.

Ann Clin Transl Neurol. 2017 Jul 28;4(9):680-686. doi: 10.1002/acn3.396. eCollection 2017 Sep.

7.

Clinical manifestations of the anti-IgLON5 disease.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, Seitz C, Simabukuro M, Téllez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaría J, Dalmau J.

Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5.

8.

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.

9.

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.

Sabater L, Planagumà J, Dalmau J, Graus F.

J Neuroinflammation. 2016 Sep 1;13(1):226. doi: 10.1186/s12974-016-0689-1.

10.

Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F.

Neurology. 2016 Aug 23;87(8):759-65. doi: 10.1212/WNL.0000000000003009. Epub 2016 Jul 27.

11.

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.

Sepúlveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, Téllez N, Midaglia L, Ariño H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A.

J Neurol. 2016 Jul;263(7):1349-60. doi: 10.1007/s00415-016-8147-7. Epub 2016 May 4.

12.

Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Armangué T, Sabater L, Torres-Vega E, Martínez-Hernández E, Ariño H, Petit-Pedrol M, Planagumà J, Bataller L, Dalmau J, Graus F.

JAMA Neurol. 2016 Apr;73(4):417-24. doi: 10.1001/jamaneurol.2015.4607.

13.

Pitfalls in the detection of CV2 (CRMP5) antibodies.

Sabater L, Saiz A, Dalmau J, Graus F.

J Neuroimmunol. 2016 Jan 15;290:80-3. doi: 10.1016/j.jneuroim.2015.11.009. Epub 2015 Dec 1.

PMID:
26711575
14.

Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration.

van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hulsenboom E, Sabater L, Hoogenraad CC, Sillevis Smitt PA.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e156. doi: 10.1212/NXI.0000000000000156. eCollection 2015 Oct. No abstract available.

15.

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies.

Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, Oliveira L, Boaventura M, Alves RC, Azevedo Soster L, Nitrini R, Gaig C, Santamaria J, Dalmau J, Graus F.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e136. doi: 10.1212/NXI.0000000000000136. eCollection 2015 Aug. No abstract available.

16.

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.

Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J.

Neurology. 2015 Jun 16;84(24):2403-12. doi: 10.1212/WNL.0000000000001682. Epub 2015 May 15.

17.

Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.

Gresa-Arribas N, Ariño H, Martínez-Hernández E, Petit-Pedrol M, Sabater L, Saiz A, Dalmau J, Graus F.

PLoS One. 2015 Mar 16;10(3):e0121364. doi: 10.1371/journal.pone.0121364. eCollection 2015.

18.

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

Höftberger R, Sepulveda M, Armangue T, Blanco Y, Rostásy K, Calvo AC, Olascoaga J, Ramió-Torrentà L, Reindl M, Benito-León J, Casanova B, Arrambide G, Sabater L, Graus F, Dalmau J, Saiz A.

Mult Scler. 2015 Jun;21(7):866-874. doi: 10.1177/1352458514555785. Epub 2014 Oct 24.

19.

Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Ariño H, Gresa-Arribas N, Blanco Y, Martínez-Hernández E, Sabater L, Petit-Pedrol M, Rouco I, Bataller L, Dalmau JO, Saiz A, Graus F.

JAMA Neurol. 2014 Aug;71(8):1009-16. doi: 10.1001/jamaneurol.2014.1011.

20.

A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaría J, Dalmau J, Graus F.

Lancet Neurol. 2014 Jun;13(6):575-86. doi: 10.1016/S1474-4422(14)70051-1. Epub 2014 Apr 3. Erratum in: Lancet Neurol. 2015 Jan;14(1):28.

Supplemental Content

Loading ...
Support Center